Unfortunately Allan Robins is unable to be with us Progress to Therapy 2012. However, in his place, we will now welcome Dr Olivia Kelly, current Director of Cell Biology at Viacyte Inc. We are very grateful and excited to welcome Olivia to Glasgow and have her discuss her topic of ES Derived Islets to Treat Type I Diabetes with us on day three.
